Publikationen in Zusammenarbeit mit Forschern von University of Virginia (29)

2024

  1. Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

    Blood cancer discovery, Vol. 5, Núm. 1, pp. 21-33

2023

  1. A novel rapamycin cream formulation improves facial angiofibromas associated with tuberous sclerosis complex: a double-blind randomized placebo-controlled trial

    The British journal of dermatology, Vol. 189, Núm. 5, pp. 520-530

  2. Alternative approaches for creating a wealth index: The case of Mozambique

    BMJ Global Health, Vol. 8, Núm. 8

  3. BOHEMIA a cluster randomized trial to assess the impact of an endectocide-based one health approach to malaria in Mozambique: baseline demographics and key malaria indicators

    Malaria Journal, Vol. 22, Núm. 1

  4. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings

    Trials, Vol. 24, Núm. 1

  5. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

2022

  1. A global experiment on motivating social distancing during the COVID-19 pandemic

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 22

  2. Erratum: A global experiment on motivating social distancing during the COVID-19 pandemic (Proceedings of the National Academy of Sciences of the United States of America (2022) 119 (e2111091119) DOI: 10.1073/pnas.2111091119)

    Proceedings of the National Academy of Sciences of the United States of America

  3. Erratum: Author Correction: A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic (Nature human behaviour (2021) 5 8 (1089-1110))

    Nature human behaviour

  4. In COVID-19 Health Messaging, Loss Framing Increases Anxiety with Little-to-No Concomitant Benefits: Experimental Evidence from 84 Countries

    Affective Science, Vol. 3, Núm. 3, pp. 577-602

2021

  1. A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic

    Nature Human Behaviour, Vol. 5, Núm. 8, pp. 1089-1110

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Potential impact of 5 years of ivermectin mass drug administration on malaria outcomes in high burden countries

    BMJ Global Health, Vol. 6, Núm. 11

2019

  1. Adjuvant chemoradiation in pancreatic cancer: Impact of radiotherapy dose on survival

    BMC Cancer, Vol. 19, Núm. 1

  2. Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

    Nature Immunology

  3. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis

    Translational Oncology, Vol. 12, Núm. 1, pp. 1-7

  4. ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

    Nature Immunology

2018

  1. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

    JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677

  2. Justice, Not happiness: Aristotle on the common good

    Polity, Vol. 50, Núm. 4, pp. 547-574

2016

  1. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial

    The Lancet, Vol. 387, Núm. 10031, pp. 1909-1920